- Home
- MTLS vs VNDA Comparison
MTLS vs VNDA Comparison
Compare MTLS & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- VNDA
- Stock Information
- Founded
- MTLS 1990
- VNDA 2002
- Country
- MTLS Belgium
- VNDA United States
- Employees
- MTLS N/A
- VNDA N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- VNDA Health Care
- Exchange
- MTLS Nasdaq
- VNDA Nasdaq
- Market Cap
- MTLS N/A
- VNDA 237.9M
- IPO Year
- MTLS 2014
- VNDA 2006
- Fundamental
- Price
- MTLS $5.51
- VNDA $4.22
- Analyst Decision
- MTLS
- VNDA Strong Buy
- Analyst Count
- MTLS 0
- VNDA 2
- Target Price
- MTLS N/A
- VNDA $16.50
- AVG Volume (30 Days)
- MTLS 131.3K
- VNDA 500.0K
- Earning Date
- MTLS 04-24-2025
- VNDA 05-07-2025
- Dividend Yield
- MTLS N/A
- VNDA N/A
- EPS Growth
- MTLS 43.31
- VNDA N/A
- EPS
- MTLS 0.17
- VNDA N/A
- Revenue
- MTLS $291,295,936.00
- VNDA $201,351,000.00
- Revenue This Year
- MTLS $6.55
- VNDA $14.36
- Revenue Next Year
- MTLS $9.21
- VNDA $44.53
- P/E Ratio
- MTLS $30.75
- VNDA N/A
- Revenue Growth
- MTLS 6.16
- VNDA 13.37
- 52 Week Low
- MTLS $3.93
- VNDA $3.85
- 52 Week High
- MTLS $9.69
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- MTLS 63.19
- VNDA 41.17
- Support Level
- MTLS $5.21
- VNDA $4.20
- Resistance Level
- MTLS $5.43
- VNDA $4.64
- Average True Range (ATR)
- MTLS 0.20
- VNDA 0.17
- MACD
- MTLS 0.09
- VNDA 0.01
- Stochastic Oscillator
- MTLS 93.39
- VNDA 20.75
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.